Targeted nucleic acid delivery into tumors: New avenues for cancer therapy

Biomedicine and Pharmacotherapy

Volumn 58, Issue 3, 2004, Pages 152-161

  Wagner, Ernst ^a   Kircheis, Ralf ^b   Walker, Greg F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Igeneon AG   (Austria)

Author keywords

Gene therapy; NA; Nucleic acid; Oncology; Targeting

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTISENSE OLIGONUCLEOTIDE; CARCINOEMBRYONIC ANTIGEN; CHITOSAN; DENDRIMER; DIETHYLAMINOETHYLDEXTRAN; DNA; DNA VACCINE; DOCETAXEL; FOLIC ACID; GANCICLOVIR; GLYCOPROTEIN GP 100; INTERLEUKIN 12; LIPID; LIPOSOME; MACROGOL; METHACRYLIC ACID METHYL ESTER; NAKED DNA; NANOCAPSULE; NANOPARTICLE; NUCLEIC ACID; OLIGOLYSINE; OLIGONUCLEOTIDE; PEPTIDE; POLY(CYANOACRYLATE); POLYETHYLENEIMINE; POLYMER; PROTEIN P53; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS VECTOR;

BACTERIAL ARTIFICIAL CHROMOSOME; CANCER IMMUNOTHERAPY; CANCER THERAPY; CELL NUCLEUS; CLINICAL TRIAL; COLON CARCINOMA; CPG ISLAND; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; ELECTRIC FIELD; ELECTROPORATION; ENDOCYTOBIOSIS; ENHANCER REGION; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE FUNCTION; GENE GUN; GENE THERAPY; GENE TRANSFER; GENETIC TRANSCRIPTION; HEAD AND NECK CANCER; HUMAN; HYDRODYNAMICS; INDUCED HYPOTHERMIA; INTERNALIZATION; JET INJECTION; LIVER CELL CARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; LUNG TUMOR; LYMPHATIC DRAINAGE; MAGNETIC FIELD; MAGNETOFECTION; MARKER GENE; MELANOMA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEIC ACID BASED THERAPY; PHOTODYNAMIC THERAPY; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA INTERFERENCE; SUICIDE GENE THERAPY; TUMOR; TUMOR IMMUNITY; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; ULTRASOUND; VIRAL GENE DELIVERY SYSTEM;

EID: 1842634414     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.01.003     Document Type: Article

References (80)

1. McCormick F. Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer. 1:2001;130-141.
2. Schatzlein A.G. Non-viral vectors in cancer gene therapy: principles and progress. Anticancer Drugs. 12:2001;275-304.
3. Gomez-Navarro J., Curiel D.T., Douglas J.T. Gene therapy for cancer. Eur J Cancer. 35:1999;867-885.
4. Wickham T.J. Ligand-directed targeting of genes to the site of disease. Nat Med. 9:2003;135-139.
5. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 41:2001;189-207.
6. Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology. 61:(Suppl 2):2001;1-13.
7. Mendelsohn J. Targeting the epidermal growth factor receptor for cancer therapy. J Clin Oncol. 20:2002;1S-13S.
8. Ruoslahti E. Specialization of tumour vasculature. Nat Rev Cancer. 2:2002;83-90.
9. Rainov N.G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther. 11:2000;2389-2401.
10. Brunner S., Sauer T., Carotta S., Cotten M., Saltik M., Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 7:2000;401-407.
11. Vacik J., Dean B.S., Zimmer W.E., Dean D.A. Cell-specific nuclear import of plasmid DNA. Gene Ther. 6:1999;1006-1014.
12. Lipinski K.S., Djeha A.H., Ismail T., Mountain A., Young L.S., Wrighton C.J. High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue. Mol Ther. 4:2001;365-371.
13. Dachs G.U., Patterson A.V., Firth J.D., Ratcliffe P.J., Townsend K.M., Stratford I.J., et al. Targeting gene expression to hypoxic tumor cells. Nat Med. 3:1997;515-520.
14. Hallahan D.E., Mauceri H.J., Seung L.P., Dunphy E.J., Wayne J.D., Hanna N.N., et al. Spatial and temporal control of gene therapy using ionizing radiation. Nat Med. 1:1995;786-791.
15. Rodriguez R., Schuur E.R., Lim H.Y., Henderson G.A., Simons J.W., Henderson D.R. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57:1997;2559-2563.
16. Brunori M., Malerba M., Kashiwazaki H., Iggo R. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway. J Virol. 75:2001;2857-2865.
17. Nemunaitis J., Swisher S.G., Timmons T., Connors D., Mack M., Doerksen L., et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol. 18:2000;609-622.
18. Baque P., Pierrefite-Carle V., Gavelli A., Brossette N., Benchimol D., Bourgeon A., et al. Naked DNA injection for liver metastases treatment in rats. Hepatology. 35:2002;1144-1152.
19. Song K., Chang Y., Prud'homme G.J. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer. Gene Ther. 7:2000;481-492.
20. Zhang G., Budker V., Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther. 10:1999;1735-1737.
21. Liu F., Song Y., Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1999;1258-1266.
22. Wang J., Murakami T., Hakamata Y., Ajiki T., Jinbu Y., Akasaka Y., et al. Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: successful treatment of oral melanoma and distant skin lesion. Cancer Gene Ther. 8:2001;705-712.
23. Aihara H., Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol. 16:1998;867-870.
24. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. 6:1999;508-514.
25. Mendiratta S.K., Thai G., Eslahi N.K., Thull N.M., Matar M., Bronte V., et al. Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2. Cancer Res. 61:2001;859-863.
26. Martel-Renoir D., Trochon-Joseph V., Galaup A., Bouquet C., Griscelli F., Opolon P., et al. Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumor growth, and antimetastatic effect. Mol Ther. 8:2003;425-433.
27. Lucas M.L., Heller L., Coppola D., Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther. 5:2002;668-675.
28. Goto T., Nishi T., Tamura T., Dev S.B., Takeshima H., Kochi M., et al. Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA. 97:2000;354-359.
29. Anwer K., Kao G., Proctor B., Anscombe I., Florack V., Earls R., et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7:2000;1833-1839.
30. Huber P.E., Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Ther. 7:2000;1516-1525.
31. Tomizawa M., Ebara M., Saisho H., Sakiyama S., Tagawa M. Irradiation with ultrasound of low output intensity increased chemosensitivity of subcutaneous solid tumors to an anti-cancer agent. Cancer Lett. 173:2001;31-35.
32. Seemann S., Hauff P., Schultze-Mosgau M., Lehmann C., Reszka R. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharm Res. 19:2002;250-257.
33. Walther W., Stein U., Fichtner I., Malcherek L., Lemm M., Schlag P.M. Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther. 8:2001;173-180.
34. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9:2002;102-109.
35. Hogset A., Prasmickaite L., Engesaeter B.O., Hellum M., Selbo P.K., Olsen V.M., et al. Light directed gene transfer by photochemical internalisation. Curr Gene Ther. 3:2003;89-112.
36. Prasmickaite L., Hogset A., Tjelle T.E., Olsen V.M., Berg K. Role of endosomes in gene transfection mediated by photochemical internalisation (PCI). J Gene Med. 2:2000;477-488.
37. Kloeckner J, Prasmickaite L, Hogset A, Berg K, Wagner E. Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes. J Drug Targeting 2004; [in press].
38. Felgner P.L., Barenholz Y., Behr J.P., Cheng S.H., Cullis P., Huang L., et al. Nomenclature for synthetic gene delivery systems [editorial]. Hum Gene Ther. 8:1997;511-512.
39. Berton M., Allemann E., Stein C.A., Gurny R. Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex. Eur J Pharm Sci. 9:1999;163-170.
40. Truong L., Walsh S.M., Schweibert E., Mao H.Q., Guggino W.B., August J.T., et al. Gene transfer by DNA-gelatin nanospheres. Arch Biochem Biophys. 361:1999;47-56.
41. Arnedo A., Espuelas S., Irache J.M. Albumin nanoparticles as carriers for a phosphodiester oligonucleotide. Int J Pharm. 244:2002;59-72.
42. Mao H.Q., Roy K., Troung L., Janes K.A., Lin K.Y., Wang Y., et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 70:2001;399-421.
43. Hood J.D., Bednarski M., Frausto R., Guccione S., Reisfeld R.A., Xiang R., et al. Tumor regression by targeted gene delivery to the neovasculature. Science. 296:2002;2404-2407.
44. Hafez I.M., Maurer N., Cullis P.R. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8:2001;1188-1196.
45. Xu Y., Szoka F.C. Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry. 35:1996;5616-5623.
46. Nabel G.J., Nabel E.G., Yang Z.Y., Fox B.A., Plautz G.E., Gao X., et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA. 90:1993;11307-11311.
47. Stopeck A.T., Jones A., Hersh E.M., Thompson J.A., Finucane D.M., Gutheil J.C., et al. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clin Cancer Res. 7:2001;2285-2291.
48. Li S., Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4:1997;891-900.
49. Ueno N.T., Bartholomeusz C., Xia W., Anklesaria P., Bruckheimer E.M., Mebel E., et al. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene. Cancer Res. 62:2002;6712-6716.
50. Whitmore M.M., Li S., Falo L. Jr, Huang L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol Immunother. 50:2001;503-514.
51. Monck M.A., Mori A., Lee D., Tam P., Wheeler J.J., Cullis P.R., et al. Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J Drug Target. 7:2000;439-452.
52. Rait A.S., Pirollo K.F., Xiang L., Ulick D., Chang E.H. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels. Mol Med. 8:2002;475-486.
53. Hofland H.E., Masson C., Iginla S., Osetinsky I., Reddy J.A., Leamon C.P., et al. Folate-targeted gene transfer in vivo. Mol Ther. 5:2002;739-744.
54. Xu L., Pirollo K.F., Tang W.H., Rait A., Chang E.H. Transferrin-liposome- mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther. 10:1999;2941-2952.
55. Ramesh R., Saeki T., Templeton N.S., Ji L., Stephens L.C., Ito I., et al. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther. 3:2001;337-350.
56. De Smedt S.C., Demeester J., Hennink W.E. Cationic polymer based gene delivery systems. Pharm Res. 17:2000;113-126.
57. Han S., Mahato R.I., Sung Y.K., Kim S.W. Development of biomaterials for gene therapy. Mol Ther. 2:2000;302-317.
58. Wagner E. Strategies to improve DNA polyplexes for in vivo gene transfer - will "artificial viruses" be the answer? Pharm Res. 21:2004;8-14.
59. Kichler A., Leborgne C., Coeytaux E., Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. J Gene Med. 3:2001;135-144.
60. Sonawane N.D., Szoka F.C. Jr, Verkman A.S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem. 278:2003;44826-44831.
61. Zou S.M., Erbacher P., Remy J.S., Behr J.P. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med. 2:2000;128-134.
62. Wightman L., Kircheis R., Rossler V., Carotta S., Ruzicka R., Kursa M., et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med. 3:2001;362-372.
63. Chollet P., Favrot M.C., Hurbin A., Coll J.L. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med. 4:2002;84-91.
64. Coll J.L., Chollet P., Brambilla E., Desplanques D., Behr J.P., Favrot M. In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum Gene Ther. 10:1999;1659-1666.
65. Gautam A., Waldrep J.C., Densmore C.L., Koshkina N., Melton S., Roberts L. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gene Ther. 9:2002;353-357.
66. Kursa M., Walker G.F., Roessler V., Ogris M., Roedl W., Kircheis R. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug Chem. 14:2003;222-231.
67. Ogris M., Brunner S., Schuller S., Kircheis R., Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:1999;595-605.
68. Dash P.R., Read M.L., Fisher K.D., Howard K.A., Wolfert M., Oupicky D., et al. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J Biol Chem. 275:2000;3793-3802.
69. Kircheis R., Wightman L., Schreiber A., Robitza B., Rossler V., Kursa M., et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8:2001;28-40.
70. Hildebrandt I.J., Iyer M., Wagner E., Gambhir S.S. Optical imaging of transferrin targeted PEI/DNA complexes in living subjects. Gene Ther. 10:2003;758-764.
71. Kircheis R., Ostermann E., Wolschek M.F., Lichtenberger C., Magin-Lachmann C., Wightman L., et al. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther. 9:2002;673-680.
72. Wolschek M.F., Thallinger C., Kursa M., Rossler V., Allen M., Lichtenberger C., et al. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology. 36:2002;1106-1114.
73. Liu X., Tian P.K., Ju D.W., Zhang M.H., Yao M., Cao X.T., et al. Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex. Cancer Gene Ther. 10:2003;529-539.
74. McKenzie D.L., Smiley E., Kwok K.Y., Rice K.G. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug Chem. 11:2000;901-909.
75. Oupicky D., Carlisle R.C., Seymour L.W. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther. 8:2001;713-724.
76. Lim Y.B., Kim S.M., Suh H., Park J.S. Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjug Chem. 13:2002;952-957.
77. Anderson D.G., Lynn D.M., Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl. 42:2003;3153-3158.
78. Jabs D.A., Griffiths P.D. Fomivirsen for the treatment of cytomegalovirus retinitis. Am J Ophthalmol. 133:2002;552-556.
79. Staba M.J., Mauceri H.J., Kufe D.W., Hallahan D.E., Weichselbaum R.R. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Ther. 5:1998;293-300.
80. Nemunaitis J., Khuri F., Ganly I., Arseneau J., Posner M., Vokes E., et al. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol. 19:2001;289-298.